title: Meeting highlights from 2nd symposium on controversies and clinical challenges in myeloma, lymphoma and leukemia.
authors.forename: G Kesava
authors.initials: GK
authors.lastname: Reddy
authors.forename: Amy
authors.initials: A
authors.lastname: D'Orazio
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents